Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest

Abstract

Our findings confirm STIM1 as a rational therapeutic target in human glioblastoma, and also indicate that lentivirus-mediated STIM1 silencing is a promising therapeutic strategy for human glioblastoma.